Genkyotex announced the appointment of Dr. Jeanette Wood as Chief Scientific Officer and Dr. Joseph McCracken to the Board of Directors. Dr. Wood joins Genkyotex with more than 30 years research experience in the pharmaceutical industry, most recently at AstraZeneca. Dr. Joe McCracken has more than 25 years of experience in technical, business development and market development roles with biotechnology and pharmaceutical companies.

Most recently he was Global Head for Business Development & Licensing at Roche Pharma. He was also at one time Director of Business Development and Representative Director of Genentech Ltd.